JP6159727B2 - 早期結腸直腸癌の検出のための血漿マイクロｒｎａ - Google Patents

早期結腸直腸癌の検出のための血漿マイクロｒｎａ Download PDF

Info

Publication number
JP6159727B2
JP6159727B2 JP2014536355A JP2014536355A JP6159727B2 JP 6159727 B2 JP6159727 B2 JP 6159727B2 JP 2014536355 A JP2014536355 A JP 2014536355A JP 2014536355 A JP2014536355 A JP 2014536355A JP 6159727 B2 JP6159727 B2 JP 6159727B2
Authority
JP
Japan
Prior art keywords
colorectal
pcr
crc
expression
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014536355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014530619A (ja
Inventor
コス，マリトクセル ヒロネジャ，イ
コス，マリトクセル ヒロネジャ，イ
サルバテジャ，ファン，ホセ ロサノ
サルバテジャ，ファン，ホセ ロサノ
ガランゴウ，アントニ カステイス，イ
ガランゴウ，アントニ カステイス，イ
ヒラルデス，マリア，ドロレス
Original Assignee
ホスピタル クリニク デ バルセロナ
ホスピタル クリニク デ バルセロナ
セントロ デ インベスティガシオン バイオメディカ エン レド デ エンフェルメダデス ヘパティカス イ ディゲスティバス
セントロ デ インベスティガシオン バイオメディカ エン レド デ エンフェルメダデス ヘパティカス イ ディゲスティバス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ホスピタル クリニク デ バルセロナ, ホスピタル クリニク デ バルセロナ, セントロ デ インベスティガシオン バイオメディカ エン レド デ エンフェルメダデス ヘパティカス イ ディゲスティバス, セントロ デ インベスティガシオン バイオメディカ エン レド デ エンフェルメダデス ヘパティカス イ ディゲスティバス filed Critical ホスピタル クリニク デ バルセロナ
Publication of JP2014530619A publication Critical patent/JP2014530619A/ja
Application granted granted Critical
Publication of JP6159727B2 publication Critical patent/JP6159727B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2014536355A 2011-10-21 2012-10-20 早期結腸直腸癌の検出のための血漿マイクロｒｎａ Active JP6159727B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161550148P 2011-10-21 2011-10-21
US61/550,148 2011-10-21
PCT/IB2012/003035 WO2013093635A2 (en) 2011-10-21 2012-10-20 Plasma micrornas for the detection of early colorectal cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015043433A Division JP6203209B2 (ja) 2011-10-21 2015-03-05 早期結腸直腸癌の検出のための血漿マイクロｒｎａ

Publications (2)

Publication Number Publication Date
JP2014530619A JP2014530619A (ja) 2014-11-20
JP6159727B2 true JP6159727B2 (ja) 2017-07-05

Family

ID=48136439

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014536355A Active JP6159727B2 (ja) 2011-10-21 2012-10-20 早期結腸直腸癌の検出のための血漿マイクロｒｎａ
JP2015043433A Active JP6203209B2 (ja) 2011-10-21 2015-03-05 早期結腸直腸癌の検出のための血漿マイクロｒｎａ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015043433A Active JP6203209B2 (ja) 2011-10-21 2015-03-05 早期結腸直腸癌の検出のための血漿マイクロｒｎａ

Country Status (18)

Country Link
US (6) US20130102487A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP2944700B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP6159727B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (2) KR101900872B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (2) CN104145024A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2012356317B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (2) BR112014009643B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2852850C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK2944700T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2662401T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HUE035614T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2015DN01855A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (2) MX357550B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO3051026T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL2944700T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (2) PT2768986T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (2) RU2611189C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2013093635A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2628355B2 (ja) 1987-09-22 1997-07-09 バクスター、インターナショナル、インコーポレイテッド 生理学的測定装置のための光ファイバープローブコネクター

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103703142A (zh) 2011-01-26 2014-04-02 西菲伊德公司 检测肺癌的方法
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
JP6275145B2 (ja) 2012-09-04 2018-02-07 ガーダント ヘルス， インコーポレイテッド まれな変異およびコピー数多型を検出するためのシステムおよび方法
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
AU2014369841B2 (en) 2013-12-28 2019-01-24 Guardant Health, Inc. Methods and systems for detecting genetic variants
CA2939343A1 (en) 2014-02-18 2015-08-27 Baylor Research Institute Mir-320e and colorectal cancer
KR20240023185A (ko) * 2014-06-13 2024-02-20 도레이 카부시키가이샤 대장암의 검출 키트 또는 디바이스 및 검출 방법
WO2016034715A2 (fr) * 2014-09-05 2016-03-10 Prestizia Methode de prediction de l'evolution clinique du cancer colorectal
CN104313142B (zh) * 2014-10-16 2016-02-03 上海交通大学医学院附属仁济医院 miRNA-30a作为标记分子在制备诊断试剂中的用途
CN104388541B (zh) * 2014-10-21 2017-07-04 复旦大学附属肿瘤医院 miR‑1914*和miR‑1915的用途
CN104372004B (zh) * 2014-12-04 2018-04-27 广东医学院 一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用
SG10201908277TA (en) * 2015-03-09 2019-10-30 Agency Science Tech & Res Method of determining the risk of developing breast cancer by detecting the expression levels of micrornas (mirnas)
EP3147370A1 (en) 2015-09-28 2017-03-29 Rheinische Friedrich-Wilhelms-Universität Bonn Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat)
WO2017106768A1 (en) 2015-12-17 2017-06-22 Guardant Health, Inc. Methods to determine tumor gene copy number by analysis of cell-free dna
CN110139936A (zh) * 2016-08-18 2019-08-16 N·特兰 口腔癌、咽癌和喉癌的生物标记
EP3327135A1 (en) * 2016-11-28 2018-05-30 Advanced Marker Discovery, S.L. In vitro method for identifying colorectal adenomas or colorectal cancer
CN106950370A (zh) * 2017-01-25 2017-07-14 上海市第十人民医院 血液微小核酸大肠癌诊断分子组合
CN107254522A (zh) * 2017-06-09 2017-10-17 中山大学附属第三医院 miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用
CN107236799B (zh) * 2017-06-15 2020-06-09 昆明医科大学第六附属医院 一种肾纤维化miRNA标记物
CN107326092B (zh) * 2017-08-25 2021-07-20 深圳市恩普电子技术有限公司 大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒
CN107746886B (zh) * 2017-09-11 2019-10-01 朱伟 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用
WO2019144183A1 (en) * 2018-01-23 2019-08-01 La Trobe University Biomarkers of colorectal cancer
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
CN110205367B (zh) * 2018-02-28 2022-06-21 伽蓝（集团）股份有限公司 一种筛选保护皮肤细胞端粒的活性物的方法
KR20210031640A (ko) * 2018-05-09 2021-03-22 덤테크, 인크. 신규한 유전자 분류자 및 자가면역 질환에서의 이의 용도
CN114438214B (zh) * 2018-06-27 2023-12-22 深圳华大生命科学研究院 结直肠癌肿瘤标志物及其检测方法与装置
CN109557311B (zh) * 2018-12-13 2022-02-15 中南大学湘雅医院 结直肠癌诊断标志物及结直肠癌的检测产品及其应用
KR102275465B1 (ko) * 2019-01-18 2021-07-09 사회복지법인 삼성생명공익재단 전이성 대장암 치료물질 스크리닝 방법
CN112041463B (zh) * 2019-03-11 2024-07-23 香港中文大学 结肠直肠癌的miRNA标志物
JP7727970B2 (ja) * 2019-07-15 2025-08-22 インスティテュ ディンベスティガシオンス ビオメディクス アウグスト ピ イ スニェール（イデイベーアーペーエセ） 結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法
CN110438227A (zh) * 2019-07-29 2019-11-12 广州中昱医学生物科技有限公司 miR-17-92在结直肠癌诊断中的用途
CN112080568A (zh) * 2020-09-27 2020-12-15 扬州大学 一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用
JP7740733B2 (ja) * 2021-08-31 2025-09-17 国立大学法人大阪大学 ２型糖尿病・大腸がんを検査する方法
CN116640862A (zh) * 2021-09-08 2023-08-25 广东积因生物有限公司 引物及试剂盒
CN113981096A (zh) * 2021-11-30 2022-01-28 无锡市疾病预防控制中心 一种用于诊断结直肠癌的血浆miRNA标志物及其应用
EP4526473A2 (en) 2022-05-20 2025-03-26 Novigenix SA Biomarkers for colorectal neoplasia
CN119144728B (zh) * 2024-11-19 2025-04-29 四川大学华西医院 原发性肝癌的MicroRNA标志物的引物、试剂盒和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GB0415277D0 (en) * 2004-07-07 2004-08-11 Colonix Ltd Apparatus and method for sampling mucosal surfaces
US7939255B2 (en) 2006-07-03 2011-05-10 Catholic University Industry Academy Cooperation Foundation Diagnostic methods for colorectal cancer
US8343719B2 (en) * 2006-10-30 2013-01-01 Research Foundation Of State University Of New York Microrna as biomarker in cancer
AU2007314212B2 (en) 2006-11-01 2014-05-29 The Govt. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services MicroRNA expression signature for predicting survival and metastases in Hepatocellular carcinoma
US20100075304A1 (en) * 2007-10-30 2010-03-25 Mitch Raponi Process for monitoring colorectal cancer
CN101424640B (zh) * 2007-11-02 2012-07-25 江苏命码生物科技有限公司 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
EP2268832A2 (en) * 2008-03-06 2011-01-05 Asuragen, INC. Microrna markers for recurrence of colorectal cancer
EP2283161A4 (en) * 2008-05-16 2012-03-28 Veridex Llc METHOD FOR ASSESSING COLORECTAL CARCINOMA AND COMPOSITIONS FOR USE THEREOF
WO2010004562A2 (en) 2008-07-09 2010-01-14 Rosetta Genomics Ltd. Methods and compositions for detecting colorectal cancer
EP2350320A4 (en) * 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHODS AND SYSTEMS FOR USING EXOSOMES TO DETERMINE PHENOTYPES
WO2010055487A2 (en) * 2008-11-13 2010-05-20 Koninklijke Philips Electronics N.V. Compositions and methods for micro-rna expession profiling of colorectal cancer
WO2010126355A1 (en) * 2009-04-29 2010-11-04 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
US20100317533A1 (en) 2009-06-05 2010-12-16 British Columbia Cancer Agency Branch Biomarkers of cancer metastasis
WO2011012136A1 (en) 2009-07-28 2011-02-03 Exiqon A/S A method for classifying a human cell sample as cancerous
CN101988060A (zh) * 2009-07-30 2011-03-23 江苏命码生物科技有限公司 结直肠癌检测标记物及其检测方法、试剂盒和生物芯片
WO2011044541A2 (en) * 2009-10-09 2011-04-14 Baylor Research Institute Identification of micrornas (mirnas) in fecal samples as biomarkers for gastroenterological cancers
WO2011076147A1 (en) 2009-12-24 2011-06-30 Fudan University Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer
WO2011076142A1 (en) * 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expession profiling in plasma of colorectal cancer
CA2787027A1 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Detection of gastrointestinal disorders
US20110318742A1 (en) * 2010-06-23 2011-12-29 The Chinese University Of Hong Kong Micro rna markers for colorectal cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2628355B2 (ja) 1987-09-22 1997-07-09 バクスター、インターナショナル、インコーポレイテッド 生理学的測定装置のための光ファイバープローブコネクター

Also Published As

Publication number Publication date
JP2015128442A (ja) 2015-07-16
BR122015004941A2 (pt) 2019-08-20
ES2688693T3 (es) 2018-11-06
PT2768986T (pt) 2018-10-23
US20150087525A1 (en) 2015-03-26
KR101900872B1 (ko) 2018-09-20
HUE035614T2 (en) 2018-05-28
EP2768986B1 (en) 2018-06-27
CN104145024A (zh) 2014-11-12
DK2768986T3 (en) 2018-09-10
US20180355439A1 (en) 2018-12-13
BR112014009643A2 (pt) 2017-12-12
PL2768986T3 (pl) 2018-12-31
HUE039522T2 (hu) 2019-01-28
KR101912731B1 (ko) 2018-10-29
JP2014530619A (ja) 2014-11-20
MX357119B (es) 2018-06-27
US20160289771A1 (en) 2016-10-06
KR20150036804A (ko) 2015-04-07
CN104651521A (zh) 2015-05-27
US20150176082A1 (en) 2015-06-25
BR122015004941B1 (pt) 2021-09-28
RU2662975C1 (ru) 2018-07-31
PT2944700T (pt) 2018-01-24
ES2662401T3 (es) 2018-04-06
NO3051026T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2018-07-28
CA2852850C (en) 2020-07-28
JP6203209B2 (ja) 2017-09-27
DK2944700T3 (en) 2018-01-22
KR20140097195A (ko) 2014-08-06
EP2944700B1 (en) 2017-10-18
AU2012356317B2 (en) 2016-04-07
WO2013093635A3 (en) 2013-09-06
MX357550B (es) 2018-07-13
CN104651521B (zh) 2021-08-27
AU2012356317A1 (en) 2014-05-15
EP2768986A2 (en) 2014-08-27
EP2944700A1 (en) 2015-11-18
CA2852850A1 (en) 2013-06-27
BR112014009643B1 (pt) 2020-12-15
MX2014004810A (es) 2014-11-25
US20130102487A1 (en) 2013-04-25
RU2611189C2 (ru) 2017-02-21
PL2944700T3 (pl) 2018-05-30
WO2013093635A2 (en) 2013-06-27
IN2015DN01855A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-07-10
US20180346996A1 (en) 2018-12-06
RU2014120427A (ru) 2015-11-27

Similar Documents

Publication Publication Date Title
JP6203209B2 (ja) 早期結腸直腸癌の検出のための血漿マイクロｒｎａ
US9068974B2 (en) Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers
EP3122905B1 (en) Circulating micrornas as biomarkers for endometriosis
KR102096498B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로RNA-4732-5p 및 이의 용도
JP2022523366A (ja) 癌の診断及び予後に関するバイオマーカーパネル
CA2830301A1 (en) Changes in the expression of mir-200c/141 cluster of micrornas as biomarkers for epithelial-to-mesenchymal transition in human colorectal cancer metastasis
WO2009025790A1 (en) Diagnostic and prognostic use of human bladder cancer-associated micro rnas
EP3529376A1 (en) Biomarkers of oral, pharyngeal and laryngeal cancers
KR102096499B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로rna-3960 및 이의 용도
US10519506B2 (en) Identification of metastasis-specific miRNA and hypomethylation signatures in human colorectal cancer
AU2015201072B2 (en) Plasma microRNAs for the detection of early colorectal cancer
WO2013096888A1 (en) Identification of metastasis-specific mirna and hypomethylation signatures in human colorectal cancer

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20141031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20141031

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160301

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160706

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170329

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20170405

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170606

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170612

R150 Certificate of patent or registration of utility model

Ref document number: 6159727

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250